Area of research
Endocrinology, Diabetes and Metabolism · Oncology
Research interest
Research interests include Thyroid Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Neuroendocrine Tumor Research Advances, and Thyroid and Parathyroid Surgery.
Hyperglycemia in patients treated with immune checkpoint inhibitors: key clinical challenges and multidisciplinary consensus recommendations
Risk Factors and Characteristics of Checkpoint Inhibitor–Associated Autoimmune Diabetes Mellitus (CIADM): A Systematic Review and Delineation From Type 1 Diabetes
Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus Is Characterized by C-peptide Loss and Pancreatic Atrophy
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma
Association of Antithyroid Antibodies in Checkpoint Inhibitor–Associated Thyroid Immune–Related Adverse Events
Immune Related Adverse Events of the Thyroid – A Narrative Review
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease
Multikinase inhibitors in thyroid cancer: timing of targeted therapy
Papillary thyroid microcarcinoma: Is active surveillance always enough?
Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic review
Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
Molecular Markers Guiding Thyroid Cancer Management
Checkpoint Inhibitor–Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes
The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma
Clinical and Molecular Characterization of a Novel PLIN1 Frameshift Mutation Identified in Patients With Familial Partial Lipodystrophy